US FDA Approves Bayers Sunharbo
The US Food and Drug Administration approved Bayers Sunharbo to prevent recurrent strokes and mini-strokes. The once-daily drug targets Factor XIa to reduce clotting risks.
Xurve View
Insights:
Xurve View
United States health regulators approved a once-daily stroke-prevention pill developed by BAYER AG-REG on Monday afternoon. The drug targets Factor XIa to prevent secondary strokes in high-risk patients. The approval offers a new therapeutic option as older blockbusters face generic competition.
